ArticleFrontiers in pediatrics2026
Twenty-five-year trends in mortality and major morbidity among very low birth weight infants at a Saudi tertiary centre: improving morbidity despite expanding resuscitation at the limits of viability.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Very low birth weight (VLBW) infants remain at high risk of mortality and major morbidity, yet longitudinal data from Saudi Arabia spanning several decades are scarce. We examined 25-year trends in survival and morbidity at a single tertiary centre, with particular attention to whether patterns reflect evolving case-mix at the limits of viability. Methods: This retrospective cohort study included inborn VLBW infants (birth weight <1,500 g, gestational age <33 weeks) admitted to the NICU of King Saud University Medical City, Riyadh, across three periods: 1999-2007 ( Results: Crude survival declined significantly across periods (88.7%, 84.0%, 79.0%; Conclusion: Expanding active resuscitation at 22-24 weeks generated an apparent decline in crude survival, while care quality markedly improved, evidenced by large reductions in sepsis, necrotising enterocolitis, and severe retinopathy. Caution is warranted in attributing the decline in crude survival solely to the change in resuscitation policy at 22-24 weeks, as evolving clinical management strategies and other policy changes over the study period may also have contributed to the observed outcomes. Standardised national benchmarking and multicentre surveillance are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.